Clinical Trials Directory

Trials / Completed

CompletedNCT04504305

To Assess the Efficacy of Investigational Product on the Neuropathic Pain in Individuals Suffering From Type II Diabetes Mellitus.

A Double-blind, Randomized, Placebo-controlled Study to Assess the Efficacy of Investigational Product Nerve Support Formula on the Neuropathic Pain in Individuals Suffering From Type II Diabetes Mellitus.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
64 (actual)
Sponsor
Vedic Lifesciences Pvt. Ltd. · Industry
Sex
All
Age
40 Years – 65 Years
Healthy volunteers
Not accepted

Summary

this study is to be carried out to examine the effect of Investigation product on diabetic individuals suffering from diabetic neuropathic pain.

Conditions

Interventions

TypeNameDescription
OTHERNeuropAWAY2 capsules thrice daily to be taken half an hour prior to meal.
OTHERMicrocystalline cellulose2 capsules thrice daily to be taken half an hour prior to meal.

Timeline

Start date
2020-07-23
Primary completion
2021-01-07
Completion
2021-02-18
First posted
2020-08-07
Last updated
2021-04-08

Locations

2 sites across 1 country: India

Source: ClinicalTrials.gov record NCT04504305. Inclusion in this directory is not an endorsement.

To Assess the Efficacy of Investigational Product on the Neuropathic Pain in Individuals Suffering From Type II Diabetes (NCT04504305) · Clinical Trials Directory